Pramiracetam - 99.0% Pure White Crystalline Powder | Potent Nootropic For Enhanced Memory And Learning Capacity
Price:
Get Latest Price
In Stock
Product Specifications
| Grade | Pharmaceutical Grade |
| Application | "Anti-Alzheimers Drug" |
| Purity | 99.0%(HPLC |
| Features | Improved memory, Enhanced learning, Nootropic effects, Potent formula, Cognitive function |
Product Overview
Key Features
CAS No.: 68497-62-1
Molecular Formula: C14H27N3O2
Molecular Weight: 269.38
Appearance: White crystal.
Spec.: 99.0%(HPLC)
Usage: Anti-Alzheimer'drug.
The main ingredient of NEUPRAMIR is pramiracetam, a pharmaceutical product with nootropic effects. Experimental studies have proved it to be effective in improving memory and learning capacity.
Pramiracetam is a nootropic drug derived from piracetam, and is more potent (I. E. Lower dosage is used). It belongs to the racetam family of nootropics.
Pramiracetam was developed based on Piracetam, and is 8-30 times stronger than Piracetam. It goes by the trade name Neupramir or Pramistar.
Company Details
Focusing on a customer-centric approach, Shanghai DND Pharm has a pan-India presence and caters to a huge consumer base throughout the country. Buy Chemical Supplies in bulk from Shanghai DND Pharm at Trade India quality-assured products.
Business Type
Exporter, Manufacturer
Employee Count
65
Establishment
2015
Related Products
4S Trans N 5 6 Dihydro 6 Methyl 7 7 Dioxido 4H Thieno 2 3 Bthiopyran 4 Yl Acetamide - Cas No: 147086-83-7
MOQ - 1 Ton/Tons
Chemvon Biotechnology (shanghai) Co. Ltd.
Shanghai, Shanghai
4-Hydroxy-2-oxopyrrolidine-N-acetamide
Trademax Pharmaceuticals & Chemicals Co., Ltd.
Shanghai, Shanghai
Naphthalene Acetamide Plant Growth Regulator - 98% Purity, White Crystalline Appearance | CAS No: 86-86-2, EINECS No: 201-704-2
MOQ - 5 Kilograms/Kilograms
Shanghai Vigor Chemical Co., Ltd.
Shanghai, Shanghai
More Products From This Seller
Seller Details
Shanghai, Shanghai
Name
Michelle Zhang
Address
Kuiwen,Dinghe, Xixia,Henan, Shanghai, Shanghai, 474593, China
acetamide in Shanghai
Report incorrect details
